Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TruBiotics
- Development stage
- Discontinued
- Lead developer
- PanTheryx
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
TruBiotics is a daily probiotic supplement developed and marketed by Bayer HealthCare. It is designed to support digestive and immune health by replenishing the gut microbiome with beneficial bacteria. The formulation typically features a proprietary blend of two well-documented probiotic strains: *Lactobacillus acidophilus* (LA-5) and *Bifidobacterium animalis* subsp. *lactis* (BB-12). These strains are intended to survive the gastrointestinal environment to colonize the intestines, where they help maintain a healthy balance of microflora, support regular digestion, and bolster the body's natural immune defenses. As a dietary supplement, it is used for general wellness and the maintenance of gastrointestinal homeostasis.
- Brand names
- TruBiotics
- Other names
- Bayer TruBiotics
Beyond the preview
Go deeper on TruBiotics.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TruBiotics.